EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RNA-Based Therapeutics in Genetic Neurodevelopmental Disorders: Bridging Molecular Genetics and Precision Medicine

Ina-Ofelia Focșa iD, Catrinel Iliescu, Cristina Pomeran, Magdalena Budișteanu, Carmen Sandu, Alice Denisa Dică, Florentina Ionela Lincă iD, Cristina Moțoiescu, Diana Bârcă iD, Ioana Minciu, Dana Craiu, Viorica Elena Rădoi

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177725 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ina-Ofelia Focșa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Precision Medicine, Neurodevelopmental Disorders, Genetic Therapy, RNA. Die Arbeit nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carol Davila University of Medicine and Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic neurodevelopmental disorders (NDDs) encompass a heterogeneous group of conditions characterized by impaired cognitive, behavioral, and neurological development resulting from pathogenic variants affecting brain development and synaptic function. Advances in molecular genetics and next-generation sequencing have significantly expanded the understanding of the genetic architecture underlying disorders such as Rett syndrome (RTT), Fragile X syndrome (FXS), Angelman syndrome (AS), and autism spectrum disorders. Beyond these classical neurodevelopmental disorders, spinal muscular atrophy (SMA) is included as a paradigmatic example of successful RNA-based therapeutic translation. Concurrently, RNA-based therapeutics have emerged as promising precision medicine strategies capable of modulating gene expression at the transcriptional and post-transcriptional levels. These approaches include antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), messenger RNA (mRNA) therapies, RNA editing technologies, and splice-modulating agents. Recent clinical successes, particularly in spinal muscular atrophy, have demonstrated the transformative potential of RNA therapeutics in neurological disease. However, substantial challenges remain, including BBB penetration, long-term safety, immune activation, and genotype-specific variability in therapeutic response. This review summarizes current advances in RNA-based therapeutics for genetic NDDs, highlighting molecular mechanisms, disease-specific therapeutic strategies, translational progress, delivery challenges, and future directions. Overall, continued progress will depend on the integration of disease biology, rational RNA therapeutic design, and effective CNS-targeted delivery, supporting the broader implementation of precision RNA medicine for genetic neurodevelopmental disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineNeurodevelopmental DisordersGenetic TherapyRNAHumansAnimalsOligonucleotides, AntisenseRNA, Small InterferingRett Syndrome

Stichwörter der Autor:innen

Angelman syndromeRNA editingRNA therapeuticsRett syndromeantisense oligonucleotidesneurodevelopmental disorderspediatric neurogeneticspersonalized medicineprecision medicinespinal muscular atrophy

Substanzen

Oligonucleotides, AntisenseRNARNA, Small Interfering

Autor:innen und Institutionen

  • Department of Medical Genetics, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Psychiatry Research Laboratory, Prof. Dr. Alexandru Obregia Clinical Hospital of Psychiatry, 041914 Bucharest, Romania.
  • Pediatric Neurology Department, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 041914 Bucharest, Romania.
  • Pediatric Neurology Department, Prof. Dr. Alexandru Obregia Clinical Hospital of Psychiatry, 041914 Bucharest, Romania.
  • Medical Genetics Laboratory, Victor Babes National Institute of Pathology, 050096 Bucharest, Romania.
  • Department of Genetics, Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania.

ORCID-Profile: Ina-Ofelia Focșa, Florentina Ionela Lincă, Diana Bârcă

Förderung

  • Carol Davila University of Medicine and Pharmacy

Zitieren

APA

Focșa, I. O., Iliescu, C., Pomeran, C., Budișteanu, M., Sandu, C., Dică, A. D., Lincă, F. I., Moțoiescu, C., Bârcă, D., Minciu, I., Craiu, D., & Rădoi, V. E. (2026). RNA-Based Therapeutics in Genetic Neurodevelopmental Disorders: Bridging Molecular Genetics and Precision Medicine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177725

Vancouver

Focșa IO, Iliescu C, Pomeran C, Budișteanu M, Sandu C, Dică AD, et al. RNA-Based Therapeutics in Genetic Neurodevelopmental Disorders: Bridging Molecular Genetics and Precision Medicine. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177725

BibTeX
@article{Foca2026,
  author = {Focșa, Ina-Ofelia and Iliescu, Catrinel and Pomeran, Cristina and Budișteanu, Magdalena and Sandu, Carmen and Dică, Alice Denisa and Lincă, Florentina Ionela and Moțoiescu, Cristina and Bârcă, Diana and Minciu, Ioana and Craiu, Dana and Rădoi, Viorica Elena},
  title = {RNA-Based Therapeutics in Genetic Neurodevelopmental Disorders: Bridging Molecular Genetics and Precision Medicine},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177725}
}
Kostenlos starten →